INTRODUCTION Neuroimaging is a standard part of the evaluation of patients with focal epilepsy and any type of epilepsy in the setting of abnormal cognitive development. In…
INTRODUCTION The purpose of this chapter will be to review selected neuropathologic substrates of intractable epilepsy, including lesions that cause seizures in infants and children, as well…
INTRODUCTION Neuroimaging in epilepsy is undergoing a renaissance. Gone are the days of just “making sure there wasn’t anything big or acute.” Thin slice MRI, fMRI, diffusion…
Childhood epilepsies are often characterized by a wide range of seizure types and accompanying comorbidities such as mental impairment or developmental delay (MI/DD), autism spectrum disorders, and…
INTRODUCTION The particular epileptic conditions outlined in this chapter are very different from each other. However, they share a similar age of onset and the presence of…
INTRODUCTION Functional neuroimaging has contributed to the surgical management of epilepsy in two ways. First, functional imaging methods have facilitated decision making regarding the optimal placement of…
Since phenytoin was introduced for the treatment of epilepsy by Merritt and Putnam in 1938, it has become one of the most widely used and extensively investigated…
Selecting the appropriate dosage form and route of administration is a crucial, but underappreciated, component in the successful treatment of children with epilepsy. For example, some children…
INTRODUCTION The possible occurrence of myoclonic epilepsy in children with nonprogressive encephalopathy has been reported in the literature for many years by various authors (1–5). However, in…
As advocated by physicians and patient activist groups, the treatment goal for patients with epilepsy is to eliminate both seizures and adverse side effects of treatment (1)….
